🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢 Trainees in #Medicine, #BiomedicalSciences, #NursingEd, #Pharmacy, & other #HealthProfessions! Academic Medicine is seeking Letters to the Editor on “the moment I knew": reflections on a pivotal moment in your professional life: ow.ly/tFFs50VwNp2. #CallForPapers #MedEd

🚨 Just released by National Cancer Institute Annual Report to the Nation 2025: Overall Cancer Statistics Most cancers in both men and women showed decreases in mortality. The incidence rates for certain cancers including #PancreaticCancer (and bile duct cancers in women) saw increases. Details:

New positive Phase 3 trial for mTNBC. Hoping ODAC still meets? Sacituzumab Govitecan Plus Pembrolizumab Improves PFS in PD-L1+ TNBC #medtwitter #bcsm targetedonc.com/view/sacituzum… via Targeted Oncology

In nature from Stanford Medicine by Max Diehn, MD/PhD & Ash Alizadeh, MD/PhD 🇺🇸 An ultrasensitive method for detection of cell-free RNA nature.com/articles/s4158… RARE-seq has a limit of detection of 0.05%, identifies ~30% of stage 1 lung cancers, and provides information on resistance mechanisms.

The rising rate of stomach cancer in women is worrisome. Probably largely driven by GIST now categorized as malignant, but there's also increasing incidence of early onset gastric cancer, typically diagnosed at late stage, diffuse histology & w poor prognosis –very concerning.

Bladder preservation in muscle-invasive bladder cancer (MIBC) is evidence-based, patient-centered, and underutilized The latest IBCG consensus in European Urology offers global expert recommendations on when, how, and for whom bladder-sparing strategies are appropriate

Greatest accomplishment of research year is growing these beauties.

Residents: Struggling to evaluate HDR Prostate Brachytherapy plans? Read this technical report from American Brachy, pre-proof available in PRO. Thanks to Lara Hathout for her mentorship. sciencedirect.com/science/articl…

10y results of FAST FORWARD (adjuvant #breastcancer RT) trial presented at #ESTRO25 by AM Brunt. Compared to 40Gy/15, 26Gy/5: 1. Non inf for IBR (even superior?) 2. Similar recurrence free interval, breast cancer interval, OS 3. No diff in PRO or toxicity Clearly 26/5 SOC for

I’m SO delighted to finally see the STAR-TREC data reported 🤩 #ESTRO25 Short course RT vs chemorad for organ preservation in early stage rectal cancer 61% vs 80% TME-free survival at 12 months ➡️ More organ preservation with long-course chemorad! #radonc #rectalcancer

Honored to spend the day with Senator Katie Boyd Britt, gaining firsthand insight into public service and leadership! Grateful for her time, her team, and her leadership on behalf of Alabama.

Delighted to share our new study, led by @annacgeraghty and Lehi Acosta , uncovering the cellular dysregulation underpinning cognitive impairment after CAR T cell therapy and a strategy to rescue this cellular and cognitive dysfunction in mice. 1/ cell.com/cell/fulltext/…

We wrote a LTE (led by Krishan Jethwa) re: some of the limitations of this study, including baseline differences in comparison groups, imperfect correlation b/w cCR and pCR - both which would bias the surgical cohort toward better outcomes.

Would argue that lymphomas are one of the most important diseases to consider adaptive RT as they are exquisitely radiosensitive, often in difficult to target locations, and many have long term survival so even small decreases in dose to OARs are likely meaningful. Excited… 1/2

🚨Revolutionizing #MedEd tool🚨 Congrats to the UC San Diego Rad Med team with Megan Orr & Michael Sherer on creating iConTutor! 👏 to the most innovative #radinc education work I’ve seen ❤️ - Feasible, effective, ⬆️ accuracy 🙏🏻 ROECSG (Rad Onc Education Collab Study Group) #ROESCG2025 for highlighting her work!

Can attest these are amazing! Your physics and rad bio vids are gold 🙏

Congrats Ethan Ludmir MD and Chad Tang, MD for this publication's recognition as a recipient of the MD Anderson Cancer Center Excellence in Science Award. #endcancer #radonc ascopubs.org/doi/10.1200/JC…

Please join us in congratulating Quynh Thu Le, our department chair, as a 2025 ASTRO Gold Medal Recipient! The Gold Medal is ASTRO's highest honor bestowed on revered members who have made outstanding contributions to radiation oncology. Congratulations, Quynh! #ASTRO2025

NYtimes cooking officially trying too hard

Everyone talks about physician compensation. Almost no one talks about overhead. We debate how much CMS pays. Why procedural specialties are paid more. How physicians are reimbursed. But that misses the real driver of dysfunction: The single most expensive, least addressed